この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1998/2/21 分で読めます
Developing Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring; Public Meeting
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing a public meeting entitled ``Developing Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring.'' The purpose of the public meeting is to provide a forum for FDA to gather information for the development of new regulations for the review of radiopharmaceutical applications as required by the Food and Drug Administration Modernization Act of 1997 (the FDAMA).
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →